Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Mainz BioMed financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$0.6

2024-05-24

Market Capitalization

$12.5 M

2024-05-24

Revenue

$895 K

FY, 2023

CreditSafe Score

?
Score changed on May 30, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2019FY, 2020FY, 2021FY, 2022FY, 2023
Revenue281.0K493.0K577.0K529.0K895.0K
Cost of goods sold246.0K285.0K291.0K347.0K386.0K
Gross profit35.0K208.0K286.0K593.0K509.0K
Gross profit margin, %12.5%42.2%49.6%112.1%56.9%
Operating expense total902.0K822.0K9.9M26.5M26.3M
Depreciation and amortization54.0K60.0K69.0K261.0K866.0K
EBITDA(867.0K)(614.0K)(9.7M)(25.9M)(25.8M)
EBITDA margin, %-308.5%-124.5%-1673.7%-4899.1%-2880.3%
EBIT(921.0K)(674.0K)(9.7M)(26.2M)(26.1M)
EBIT margin, %-327.8%-136.7%-1685.6%-4948.4%-2921.5%
Interest expense202.0K268.0K2.4M210.0K810.0K
Pre tax profit(957.0K)(587.0K)(11.7M)(26.4M)(26.3M)
Net Income(957.0K)(587.0K)(11.7M)(26.4M)(26.3M)

Footer menu